The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
An updated systematic review and meta-analysis of randomized controlled trials on duration of chemotherapy for advanced non-small cell lung cancer.
Yu Yang Soon
No relevant relationships to disclose
Martin R. Stockler
No relevant relationships to disclose
Lisa Askie
No relevant relationships to disclose
Michael J. Boyer
Consultant or Advisory Role - Sanofi
Honoraria - Lilly; Pfizer